Neumirna Therapeutics, a biotechnology company developing RNA-based therapies for neurological diseases, today announced the appointment of Ellen K. Donnelly, Ph.D. as Chief Executive Officer.

Gene therapy for Huntington’s disease, a rare degenerative brain disorder, has succeeded for the first time in the United ...

In six massive laboratory freezers at the University of Utah, nearly 40,000 blood samples wait in frozen stasis.

Unwanted hair growth, mood swings, acne, weight gain or difficulty losing weight, and irregular or absent periods are all signs that someone is going through puberty.But for one in eight women ...

We’ve come too far to go back to a time when autism was defined solely in terms of deficits and mothers were made to feel guilty.

Doctors are experimenting with using lower doses of blockbuster cancer drugs. It could help hundreds of thousands of lives — if pharmaceutical companies would allow it.

Frank Menniti shares lab space for his work as chief science officer for a company developing a new drug for Alzheimer’s ...

When President Donald Trump’s administration announced it would repurpose an old, generic drug as a new treatment for autism, it came as a surprise to many experts — including the physician who ...

The new research will leverage nearly 40,000 blood samples to learn how blood pressure control could change the course of ...

Applying for a Ph.D. in psychology? Here’s a step-by-step prep guide, plus insights and favorite resources to help you stand out and succeed.

Suicide Prevention Month in September brings awareness to one of the leading causes of death in the United States, especially ...

Weight loss supplements are a big industry, but do they actually work? A dietitian explores the evidence, efficacy, and ...